Jeantet advises Medical Devices Venture on its listing on the euronext access + Paris market
Paris, on February 11, 2022, Jeantet advised Medical Devices Venture, a MedTech investment and acceleration platform, on its listing on the Euronext Access + Paris market, by way of direct admission following a €2.3 million private placement with industrial and financial investors in France and internationally.
Medical Devices Venture, a subsidiary of Archos (itself listed on the Euronext Growth Paris market), aims at building a leading French industrial group through a portfolio of MedTech companies offering innovative technologies based on medical devices or technologies serving healthcare, which can be industrialized on a large scale and in market segments offering the potential to hold leading niche positions.
The market capitalization of Medical Devices Ventures is approximately €14.3 million based on the €2.3 million private placement completed in the context of the listing.
The shares of Medical Devices Venture have been listed on the Euronext Access + Paris market since February 10, 2022 (ISIN: FR0014006PT9 / Mnemonic: MLMDV).
The purpose of the listing is to enable Medical Devices Venture to obtain better liquidity for its shares for all its shareholders, to gain visibility and to raise new funds to continue its development and that of its shareholdings.
In addition, Medical Devices Venture is considering, subject to market conditions and Euronext approval, a transfer on Euronext Growth Paris during 2022.
Allegra Finance acted as listing sponsor and Champeil as investment services provider.
Jeantet (legal counsel of Medical Devices Venture): Cyril Deniaud (Partner, Capital Markets) and Guillaume Soulé (Associate, Capital Markets).